Concepedia

Toshiki Masuishi

TM

54

Publications

2.4K

Citations

24

H-Index

2015

Active since

Affiliations

Aichi Cancer Center(Current)

National Cancer Center Hospital East

Shikoku Cancer Center

Saitama Cancer Center

The University of Texas MD Anderson Cancer Center

Toshiki Masuishi is an author at Aichi Cancer Center specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2015–2024

54

Publications

54

Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

Salvatore Siena, Maria Di Bartolomeo, Kanwal Raghav et al. · The Lancet Oncology · 2021 · 392 citations

, , +5

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero et al. · The Lancet · 2023 · 279 citations · Full text

, , +6

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato et al. · Nature Medicine · 2021 · 233 citations · Full text

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav et al. · Nature Communications · 2023 · 138 citations · Full text

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer

Kazunori Honda, Bishal Gyawali, Masashi Ando et al. · Journal of Global Oncology · 2019 · 85 citations · Full text

Rows per page

1–5 of 54